|
KMID : 1146120150010010023
|
|
Journal of Mucopolysaccharidosis and Rare Diseases
2015 Volume.1 No. 1 p.23 ~ p.27
|
|
|
Technology Trends of Growth Hormone and Development Strategies for Growtropin
|
|
Seo Kwang-Seok
|
|
|
Abstract
|
|
|
|
Recent research trends of human growth hormone (hGH) are divided into improved first-generation products, long-acting second-generation products, and biosimilar products. Among the improved first-generation products studies, studies of injection devices are being actively conducted. The long-acting second-generation products are focused on extending the half-life of hGH, and depending on the results of the clinical trials, the candidates are expected to lead the future hGH market. Finally, biosimilar has had less impact on the hGH market before now; however, expectations of low-cost products still remainas an opportunity.
|
|
|
KEYWORD
|
|
|
Growtropin, Human growth hormone (hGH), Biosimilar, Pen device, Long-acting product
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|